Table E2.
%WA for segmental airways for asthmatic patients, patients with COPD, and healthy control subjects
| Asthmatic patients | Patients with COPD | Healthy subjects | Significance (P value) | |
|---|---|---|---|---|
| RB1 %WA | 62.7 (3.97) | 64.0 (3.54) | 61.3 (3.39) | .13* .03† .001‡ |
| RB2 %WA | 61.8 (3.41) | 62.3 (3.61) | 59.4 (3.65) | .54* 1E-4† 2E-5‡ |
| RB3 %WA | 60.1 (3.67) | 60.4 (3.91) | 57.9 (3.98) | .79 .001† .001‡ |
| RB4 %WA | 63.3 (3.63) | 63.7 (3.17) | 61.7 (3.23) | .65* .02† .005‡ |
| RB5 %WA | 62.8 (3.06) | 62.6 (3.33) | 60.3 (2.38) | .93* 6E-6† 2E-4‡ |
| RB6 %WA | 61.4 (4.52) | 61.4 (4.53) | 58.1 (3.95) | 1* 1E-4† .001‡ |
| RB7 %WA | 64.6 (3.71) | 66.0 (2.72) | 63.3 (3.19) |
.02* .07† 2E-4‡ |
| RB8 %WA | 62.8 (3.45) | 64.0 (3.16) | 60.9 (2.89) |
.04* .001† 2E-6‡ |
| RB9 %WA | 63.6 (3.23) | 64.4 (2.93) | 62.1 (3.56) | .28* .01† .001‡ |
| RB10 %WA | 61.2 (3.30) | 61.6 (3.44) | 59.3 (3.43) | .71* .002† .001‡ |
| LB1 %WA | 63.9 (2.88) | 64.3 (2.84) | 62.1 (2.68) | .61* .001† 1E-4‡ |
| LB2 %WA | 64.8 (3.04) | 64.6 (2.98) | 62.6 (4.12) | .94* 4E-4† .004‡ |
| LB3 %WA | 60.5 (3.92) | 60.9 (4.42) | 58.9 (3.35) | .8* .04† .02‡ |
| LB4 %WA | 62.4 (3.65) | 63.1 (3.47) | 61.1 (3.73) | .53* .08† .02‡ |
| LB5 %WA | 63.6 (3.21) | 63.8 (2.97) | 62.1 (2.45) | .87* .007† .006‡ |
| LB6 %WA | 59.4 (4.56) | 59.0 (4.78) | 56.1 (3.41) | .85* 4E-5† .001‡ |
| LB1+2 %WA | 62.1 (4.17) | 61.3 (4.54) | 59.8 (4.34) | .42* .005† .14‡ |
| LB8 %WA | 62.5 (3.60) | 62.1 (4.30) | 59.6 (4.08) | .73* 4E-5† .003‡ |
| LB9 %WA | 63.4 (3.65) | 63.3 (3.42) | 61.4 (3.84) | .96* .002† .01‡ |
| LB10 %WA | 61.1 (3.88) | 61.3 (3.70) | 58.7 (3.39) | .87* 3E-4† 4E-4‡ |
| Right segmental mean %WA | 62.50 (2.29) | 62.9 (2.45) | 60.4 (2.24) | .53* 2E-7† 7E-8‡ |
| Left segmental mean %WA | 62.42 (2.34) | 62.4 (2.36) | 60.3 (2.28) | .98* 9E-8† 4E-6‡ |
Data are expressed as means (SDs). Intergroup comparison: The P value for 1-way ANOVA has been presented unless the ANOVA result was significant (P < .05), in which case the P value has been presented for Tukey test pairwise comparisons: *asthmatic patients versus patients with COPD, †asthmatic patients versus healthy subjects, and ‡patients with COPD versus healthy subjects.